Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-027652

NovoCure Ltd · NVCR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael J. Ambrogi
Officer — Chief Operating Officer
Period of report
May 1, 2018
Accepted (ET)
May 3, 2018 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1May 1, 2018M28,695$3.44A175,253D
Ordinary SharesF1May 1, 2018M31,305$7.03D206,558D
Ordinary SharesF2May 1, 2018S60,000$27.40D146,558D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Options to Buy Ordinary SharesF3$3.44May 1, 2018M8,695D—Dec 13, 2021Ordinary Shares8,69520,000D
Options to Buy Ordinary SharesF3$3.44May 1, 2018M20,000D—Dec 13, 2021Ordinary Shares20,0000D
Options to Buy Ordinary SharesF3$7.03May 1, 2018M20,000D—Feb 19, 2023Ordinary Shares20,00015,195D
Options to Buy Ordinary SharesF3$7.03May 1, 2018M11,305D—Feb 19, 2023Ordinary Shares11,3053,890D

Explanation of responses